AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
AbbVie is a Dividend King with a juicy yield. Coca-Cola has increased its dividend for 63 consecutive years and will likely soon extend that streak.

Best Dividend Kings: January 2026

10:11pm, Sunday, 25'th Jan 2026
Dividend Kings underperformed SPY in 2025, averaging 4.91% total return versus SPY's 17.72%, though 14 Kings outperformed the index. 2026 began strongly for Dividend Kings, up 4.66% through January 23
Cullen Frost Bankers Inc. trimmed its stake in AbbVie Inc. (NYSE: ABBV) by 3.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
First Citizens Bank and Trust Co. trimmed its position in shares of AbbVie Inc. (NYSE: ABBV) by 6.5% during the third quarter, according to the company in its most recent Form 13F filing with the Secu
Commerzbank Aktiengesellschaft FI cut its position in AbbVie Inc. (NYSE: ABBV) by 30.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchang
ABBV has rebounded after Humira patent cliff, with Skyrizi and Rinvoq driving growth. Rising estimates and a pipeline set to power earnings into 2029 bode well.
These stocks offer yields of more than double the S&P 500 average.

My Top 4 Stocks to Buy in Early 2026

05:45am, Thursday, 22'nd Jan 2026
Alphabet and Nvidia offer investors a smart way to get exposure to the AI wave. AbbVie and Interactive Brokers can prove to be resilient long-term picks.
Summary Essex LLC raised its stake in AbbVie Inc (ABBV) by 23.21%, purchasing 1,060 shares to own 5,627 shares valued at about $1,285,630 as of the lat
Dynasty Wealth Management LLC purchased a new position in shares of AbbVie Inc. (NYSE: ABBV) in the third quarter, according to the company in its most recent filing with the Securities and Exchange C
Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie's immunosuppressant portfolio helps it to produce steady revenue and profits.
Campbell and CO Investment Adviser LLC purchased a new stake in shares of AbbVie Inc. (NYSE: ABBV) in the third quarter, according to its most recent filing with the SEC. The firm purchased 5,480 shar
AbbVie has increased its dividend by 333% since 2013. Coca-Cola is a Dividend King that still has plenty of growth potential.
Dividend-paying stocks can be great for investors of any age. The income they deliver can be invested in more shares of stock.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE